EN
HI
Mahamaya Lifesciences Chart
Mahamaya Lifesciences Share Key Metrics
Volume
39600.00
Market Cap
401.86 CR
LTQ@LTP
2400@177.00
ATP
176.46
Var Margin
53.5 %
Circuit Range
137.4-206
Delivery %
70.59 %
Value
69.88 L
ASM/GSM
No
Market Lot
1200
Summary
Mahamaya Lifesciences share price is ₹177 as of 10 Jun, 2026. The stock Mahamaya Lifesciences intraday movement has stayed between ₹175.00 and ₹178.50, while on a 52-week basis,Mahamaya Lifesciences price 52 week high is ₹205.05 & its 52 week low is ₹111.00.
In terms of trading activity, Mahamaya Lifesciences has recorded a volume of 39600 shares, The Mahamaya Lifesciences has a market cap of ₹23405000 CR. The stock’s Average Traded Price (ATP) stands at ₹176.46, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2400 @ ₹177.00.
Mahamaya Lifesciences operates within a circuit range of ₹137.40 – ₹206.00, with a Value of ₹69.88 L. The Delivery Percentage for the day is 70.59%. Additionally, Mahamaya Lifesciences currently falls under the No framework, and trades with a market lot size of 1200.
Mahamaya Lifesciences Fundamentals
P/E Ratio
24.32
P/B Ratio
3.53
Div. Yield
0
Sector P/E
34.54
Sector P/B
2.2
Sec. Div. Yield
0.36
Mahamaya Lifesciences Resistance and Support
Pivot 170.22
Resistance
First Resistance
180.44
Second Resistance
189.17
Third Resistance
199.39
Support
First Support
161.49
Second Support
151.27
Third Support
142.54
Mahamaya Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-25 | Audited Results |
| 2025-12-02 | Half Yearly Results |
Mahamaya Lifesciences News
Mahamaya Lifesciences Ltd - 544611 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Mahamaya Lifesciences announced its audited financial results for FY26. The company reported a significant year-on-year growth with revenue up 24.50% to Rs.328.87 crore and net profit rising 28.97% to Rs.16.52 crore.
May 26 2026 13:13:48
Mahamaya Lifesciences Ltd - 544611 - Board Meeting Outcome for Audited Financial Results (Standalone & Consolidated) For The Half Year And Year Ended On 31.03.2026
Mahamaya Lifesciences reported FY26 cons. revenue of ₹328.87 crore, a 24.5% YoY increase, and net profit of ₹16.52 crore, up 28.9% YoY. Statutory auditors issued an unmodified opinion on both standalone and consolidated financial results for the period ended March 31, 2026.
May 25 2026 13:38:52
Read More
Mahamaya Lifesciences Management
| Name | Position |
|---|---|
| Krishnamurthy Ganesan | Managing Director |
| Prashant Krishnamurthy | Executive Director |
Mahamaya Lifesciences Similar Stocks
Kriti Industries (India) Ltd.
71.25
0.25 (0.35%)
Keltech Energies Ltd.
5250.00
-21.05 (0.40%)
Beezaasan Explotech Ltd.
295.50
15.25 (5.44%)
Dhabriya Polywood Ltd.
352.00
-0.05 (0.01%)
Shri Venkatesh Refineries Ltd.
250.00
-6.40 (2.50%)
Harrisons Malayalam Ltd.
195.60
-2.40 (1.21%)
PIL ITALICA Lifestyle Ltd.
8.30
0.30 (3.75%)
Rama Phosphates Ltd.
118.50
-1.20 (1.00%)
Shivalik Rasayan Ltd.
237.50
0.40 (0.17%)
Mahamaya Lifesciences FAQs
The Buying Price of Mahamaya Lifesciences share is 177 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Mahamaya Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Mahamaya Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Mahamaya Lifesciences shares is 24.32. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Mahamaya Lifesciences shares is 3.53. Useful to assess the stock's value relative to its book value.
To assess Mahamaya Lifesciences’s valuation compare Sector P/E, P/B which are 34.54 & 2.2 with sector averages, along with growth rates and financial metrics.
The Market Cap of Mahamaya Lifesciences is 401.86 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Mahamaya Lifesciences share price is 205.05 & 111.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Mahamaya Lifesciences belongs to the Chemicals sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
